用于抑制气管输管诱导的血液动力学升高的奥利塞里丁有效剂量:一个上下序列试验
Jianmang Yu1,2, Shiyou Wei3,4, Dandan Ling4,5
1Department of Anesthesiology, Tianmen First People's Hospital, Tianmen, Hubei, 431700, People's Republic of China.
Drug design, development and therapy
|January 1, 2026
概括
对于抑制气管管道输液反应,奥利塞里丁 (ED95) 的有效剂量在年轻人中约为55μg/kg,在老年患者中约为50μg/kg,这表明与年龄相关的剂量要求存在差异.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 在全身麻醉期间的气管输管可以引起显著的血液动力学反应.
- 奥利塞里丁是一种新型止痛药,有可能控制这些反应.
- 年龄可以影响药物的药理动力学和药理动力学,可能影响剂量.
研究的目的:
- 为了确定奥利塞里丁的有效剂量,以抑制气管管道输入的血液动力学反应.
- 为了研究年龄对奥利塞里丁剂量要求的影响.
- 为优化临床药物治疗方案提供证据.
主要方法:
- 潜在的,单中心,使用修改的迪克森上下方法的顺序剂量试验.
- 患者分为年轻人 (18-65岁) 和老年人 (≥65岁) 组.
- 使用Probit回归计算ED50和ED95,根据心血管反应进行调整.
主要成果:
- 年轻组的ED95为55.4μg/kg,老年组为50.11μg/kg.
- 100%的镇静成功率没有注射相关的咳观察到.
- 周周输液后的血液动力学变化在各组之间是相似的,具有可比的不良事件发生率.
结论:
- 对于抑制气管管道输液诱导的血液动力学升高的有效剂量,存在与年龄相关的差异.
- 奥利塞里丁在麻醉诱导期间管理血液动力学反应的有效性和安全性.
- 这些发现支持根据患者年龄量身定制的奥利塞里丁剂量.
相关概念视频
Depolarizing Blockers: Pharmocokinetics
547
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
547
Parenteral Anesthetics: Overview
540
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
540
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
212
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
212


